{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:56:44Z","timestamp":1792799804204,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Stichting BeterKeten"},{"name":"Stichting Onderzoek Franciscus"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11695-025-08392-5","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T01:57:12Z","timestamp":1766973432000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bariatric Surgery Reduces Epicardial Adipose Tissue and is Associated with Improved Cardiac Function"],"prefix":"10.1007","volume":"36","author":[{"given":"Jie Fen","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaar S.","family":"Aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Abou Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne M","family":"Snelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemien L","family":"Verloop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J","family":"Brugts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas M.","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"8392_CR1","unstructured":"WHO European Regional Obesity Report. 2022. Copenhagen. WHO Regional Office for Europe. 2022."},{"issue":"3","key":"8392_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","volume":"4","author":"M Haass","year":"2011","unstructured":"Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail. 2011;4(3):324\u201331.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"8392_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 2018;6(8):701\u20139.","journal-title":"JACC Heart Fail"},{"issue":"11","key":"8392_CR4","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/ejhf.3011","volume":"25","author":"JF Chin","year":"2023","unstructured":"Chin JF, Aga YS, Abou Kamar S, Kroon D, Snelder SM, van de Poll SWE, et al. Association between epicardial adipose tissue and cardiac dysfunction in subjects with severe obesity. Eur J Heart Fail. 2023;25(11):1936\u201343.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"8392_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593\u2013606.","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"8392_CR6","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","volume":"43","author":"SL van Veldhuisen","year":"2022","unstructured":"van Veldhuisen SL, Gorter TM, van Woerden G, de Boer RA, Rienstra M, Hazebroek EJ, et al. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2022;43(20):1955\u201369.","journal-title":"Eur Heart J"},{"issue":"9","key":"8392_CR7","doi-asserted-by":"publisher","first-page":"100657","DOI":"10.1016\/j.jacadv.2023.100657","volume":"2","author":"SA Goldman","year":"2023","unstructured":"Goldman SA, Requena-Ibanez JA, Devesa A, Santos-Gallego CG, Badimon JJ, Fuster V. Uncovering the role of epicardial adipose tissue in heart failure with preserved ejection fraction. JACC Adv. 2023;2(9):100657.","journal-title":"JACC Adv"},{"issue":"11","key":"8392_CR8","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1007\/s11695-023-06848-0","volume":"33","author":"JPS Pereira","year":"2023","unstructured":"Pereira JPS, Calafatti M, Martinino A, Ramnarain D, Stier C, Parmar C, et al. Epicardial adipose tissue changes after bariatric and metabolic surgery: a systematic review and Meta-analysis. Obes Surg. 2023;33(11):3636\u201348.","journal-title":"Obes Surg"},{"issue":"12","key":"8392_CR9","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/ejhf.2741","volume":"24","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Westenbrink BD, de Boer RA, Rienstra M, Gorter TM. Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives. Eur J Heart Fail. 2022;24(12):2238\u201350.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"8392_CR10","doi-asserted-by":"publisher","first-page":"e025585","DOI":"10.1136\/bmjopen-2018-025585","volume":"8","author":"SM Snelder","year":"2018","unstructured":"Snelder SM, de Groot-de Laat LE, Biter LU, Castro Cabezas M, van de Geijn GJ, Birnie E, et al. Cross-sectional and prospective follow-up study to detect early signs of cardiac dysfunction in obesity: protocol of the CARDIOBESE study. BMJ Open. 2018;8(12):e025585.","journal-title":"BMJ Open"},{"issue":"3","key":"8392_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"8392_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","volume":"17","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321\u201360.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"8392_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","volume":"22","author":"G Iacobellis","year":"2009","unstructured":"Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22(12):1311\u20139. quiz 417\u20138.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"8392_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","volume":"16","author":"JU Voigt","year":"2015","unstructured":"Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015;16(1):1\u201311.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"8392_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ehjci\/jeaa091","volume":"21","author":"J-U Voigt","year":"2020","unstructured":"Voigt J-U, M\u0103l\u0103escu G-G, Haugaa K, Badano L. How to do LA strain. Eur Heart J - Cardiovasc Imaging. 2020;21(7):715\u20137.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"6","key":"8392_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2018;19(6):591\u2013600.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"10","key":"8392_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.echo.2021.05.009","volume":"34","author":"P Jeyaprakash","year":"2021","unstructured":"Jeyaprakash P, Moussad A, Pathan S, Sivapathan S, Ellenberger K, Madronio C, et al. A systematic review of scaling left atrial size: are alternative indexation methods required for an increasingly obese population? J Am Soc Echocardiogr. 2021;34(10):1067\u201376. e3.","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"8392_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/jhh.2009.16","volume":"23","author":"C Cuspidi","year":"2009","unstructured":"Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, et al. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? J Hum Hypertens. 2009;23(11):728\u201334.","journal-title":"J Hum Hypertens"},{"issue":"5","key":"8392_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1007\/s11695-015-1866-5","volume":"26","author":"R Aggarwal","year":"2016","unstructured":"Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes. Obes Surg. 2016;26(5):1030\u201340.","journal-title":"Obes Surg"},{"key":"8392_CR20","doi-asserted-by":"publisher","first-page":"1092777","DOI":"10.3389\/fendo.2023.1092777","volume":"14","author":"JA Henry","year":"2023","unstructured":"Henry JA, Abdesselam I, Deal O, Lewis AJ, Rayner J, Bernard M, et al. Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometry. Front Endocrinol (Lausanne). 2023;14:1092777.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"8392_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncpcardio0319","volume":"2","author":"G Iacobellis","year":"2005","unstructured":"Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536\u201343.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"7","key":"8392_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1055\/s-2008-1062724","volume":"40","author":"G Iacobellis","year":"2008","unstructured":"Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res. 2008;40(7):442\u20135.","journal-title":"Horm Metab Res"},{"issue":"1","key":"8392_CR23","doi-asserted-by":"publisher","first-page":"12127","DOI":"10.1038\/s41598-021-91393-y","volume":"11","author":"JR Villarreal-Calderon","year":"2021","unstructured":"Villarreal-Calderon JR, Cuellar-Tamez R, Castillo EC, Luna-Ceron E, Garcia-Rivas G, Elizondo-Montemayor L. Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery. Sci Rep. 2021;11(1):12127.","journal-title":"Sci Rep"},{"issue":"1","key":"8392_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CRD.0000000000000378","volume":"30","author":"S Anvari","year":"2022","unstructured":"Anvari S, Lee Y, Lam M, Wong JA, Hong D, Doumouras AG. Effect of bariatric surgery on natriuretic peptide levels: A systematic review and Meta-Analysis. Cardiol Rev. 2022;30(1):8\u201315.","journal-title":"Cardiol Rev"},{"issue":"16","key":"8392_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jacc.2022.08.738","volume":"80","author":"H Sorimachi","year":"2022","unstructured":"Sorimachi H, Obokata M, Omote K, Reddy YNV, Takahashi N, Koepp KE, et al. Long-Term changes in cardiac structure and function following bariatric surgery. J Am Coll Cardiol. 2022;80(16):1501\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"8392_CR26","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ejhf.2337","volume":"23","author":"NR Pugliese","year":"2021","unstructured":"Pugliese NR, Paneni F, Mazzola M, De Biase N, Del Punta L, Gargani L, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021;23(11):1858\u201371.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"8392_CR27","doi-asserted-by":"publisher","first-page":"e009238","DOI":"10.1161\/CIRCHEARTFAILURE.121.009238","volume":"15","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Manintveld OC, van Empel VPM, Willems TP, de Boer RA, et al. Epicardial adipose tissue and outcome in heart failure with Mid-Range and preserved ejection fraction. Circ Heart Fail. 2022;15(3):e009238.","journal-title":"Circ Heart Fail"},{"issue":"1","key":"8392_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.numecd.2019.08.007","volume":"30","author":"V Parisi","year":"2020","unstructured":"Parisi V, Petraglia L, Formisano R, Caruso A, Grimaldi MG, Bruzzese D, et al. Validation of the echocardiographic assessment of epicardial adipose tissue thickness at the Rindfleisch fold for the prediction of coronary artery disease. Nutr Metab Cardiovasc Dis. 2020;30(1):99\u2013105.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"8392_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ejhf.2156","volume":"23","author":"J Tromp","year":"2021","unstructured":"Tromp J, Bryant JA, Jin X, van Woerden G, Asali S, Yiying H, et al. Epicardial fat in heart failure with reduced versus preserved ejection fraction. Eur J Heart Fail. 2021;23(5):835\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"8392_CR30","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.echo.2019.07.019","volume":"32","author":"SM Snelder","year":"2019","unstructured":"Snelder SM, Younge JO, Dereci A, van Velzen JE, Akkerhuis JM, de Groot-de Laat LE, et al. Feasibility and reproducibility of transthoracic echocardiography in obese patients. J Am Soc Echocardiogr. 2019;32(11):1491\u20133. e5.","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08392-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08392-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:21:57Z","timestamp":1772547717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08392-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["8392"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08392-5","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that patient consent forms have been obtained for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent Statement"}},{"value":"The institution of Dr. De Boer has received research grants and\/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, NovoNordisk, and Roche; Dr. de Boer has had speaker engagements with and\/or received fees from and\/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, NovoNordisk, Roche, and Zoll; Dr. de Boer received travel support from Abbott and NovoNordisk. Dr. Kardys received travel reimbursement from Olink and SomaLogic. The institution of Dr. Van Dalen received research grants from Biotronik SE & Co. KG, Boehringer Ingelheim, Pfizer, Daiichi Sankyo, Sanofi and Novo Nordisk. Dr Brugts reports speaker engagement with Astra Zeneca, Abbott, Bayer, Boehringer, Novartis and Vifor in the past 5 years not related to the current work. The remaining authors report no relationships that could be construed as a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}